BridgeMD
New treatment option for Educational Materials for Genetic Testing
Official title Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
ClinicalTrials.gov ID: NCT04751435
What this study is testing
- What it's testing
- Genetic testing is a type of test that detects changes to the genes-the DNA instructions that are passed on from the mother and father. The results of a genetic test can confirm whether the participant has a genetic disorder, which is a disease caused in whole or in part by changes to the genes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Phase 1
- Age ≥ 18 years as per self-report
- Current or previous diagnosis of breast, ovarian, pancreatic, or prostate cancer as per self-report
- Self-identification as Black, Latino, and/or neither Black nor Latino (i.e.,non-Latino, Non black)
- Fluency in English, Haitian Creole, or Spanish as per self-report (for Spanish, we will attempt to recruit a cohort representing a variety of regions...
You likely can't join if
- Phase 1:
- Individuals of impaired decision-making capacity as per a clinician's or consenting professional's judgment.
- people who indicate level of fluency as "not at all" or "not well". Phase 2:
- Individuals of impaired decision-making capacity as per a clinician's or consenting professional's judgment.
- people who indicate level of fluency as "not at all" or "not well".
See the full eligibility criteria
- Phase 1
- Age ≥ 18 years as per self-report
- Current or previous diagnosis of breast, ovarian, pancreatic, or prostate cancer as per self-report
- Self-identification as Black, Latino, and/or neither Black nor Latino (i.e.,non-Latino, Non black)
- Fluency in English, Haitian Creole, or Spanish as per self-report (for Spanish, we will attempt to recruit a cohort representing a variety of regions where Spanish is spoken, as informed by current data from...
- Age ≥ 18 years as per the medical record and/or clinician referral
- Current or previous diagnosis of breast, colorectal, ovarian, pancreatic, or prostate cancer meeting at least one of the applicable criteria for the cancer type as per the medical record and/or clinician referral:
- Breast cancer criteria:
- any diagnosis age 65 or younger;
- diagnosis of triple negative breast cancer at any age;
- multiple primary breast cancers at any age;
- under consideration for PARP therapy;
- any family history (1st, 2nd, or 3rd degree relatives) of ovarian or pancreas cancer, or 1 relative with breast cancer who meets the above criteria, or 2 relatives with breast cancer at any age; or clinician discretion)
- Colorectal cancer criteria:
- any diagnosis age 50 and below;
- mismatch repair deficient colorectal cancer;
- colorectal cancer at any age with an additional Lynch syndromerelated primary cancer at any age;
- colorectal cancer at any age with a 1st or 2nd degree relative with colorectal cancer at/before age 50;
- colorectal cancer at any age with 2 or more 1st or 2nd degree relatives with a Lynch syndrome-related cancer at any age
- Ovarian cancer criteria: ° invasive ovarian cancer
- Pancreatic cancer criteria: ° pancreatic adenocarcinoma
- Prostate cancer criteria:
- castrate-resistant, metastatic prostate cancer;
- high-risk prostate cancer (pending pathology definition)
- Fluency in English, Haitian Creole, or Spanish as per self-report. Fluency is defined as an answer of "well" or "very well" on the screening questions for spoken ability
- No prior cancer genetic counseling or germline testing for cancer risk as per self-report clinician's note, and/or no clinical documentation
- Phase 1:
- Individuals of impaired decision-making capacity as per a clinician's or consenting professional's judgment.
- people who indicate level of fluency as "not at all" or "not well". Phase 2:
- Individuals of impaired decision-making capacity as per a clinician's or consenting professional's judgment.
- people who indicate level of fluency as "not at all" or "not well".
The study team makes the final eligibility decision.
Where it's taking place
- Brooklyn, New York, United States
- Jamaica, New York, United States
- New York, New York, United States
- Richmond Hill, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brooklyn, New York, United States; Jamaica, New York, United States; New York, New York, United States; Richmond Hill, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.